Effects of Skeletal Anchored Maxillary Expander for Constricted Maxilla
Launched by SAMAR HASSAN MAHMOUD MOHAMED · Jun 17, 2025
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called a skeletal anchored maxillary expander, which is used to widen a narrow upper jaw (also known as a constricted maxilla). The study aims to see how well this device works in patients of different ages who have this condition, particularly those who have issues like a crossbite, where the upper teeth don’t line up properly with the lower teeth.
People who might be eligible for this trial are teenagers and adults who have a narrow upper jaw and either one-sided or two-sided crossbites. Participants need to be in good overall health, have good oral hygiene, and should not have had previous orthodontic treatment or any diseases that affect bone health. People with certain conditions like cleft lip and palate or a history of gum disease will not be eligible. While the study is not yet recruiting participants, those who join can expect to receive this specific treatment and have their progress carefully monitored to see how well the expander works across different ages.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Skeletal maxillary transverse deficiency.
- • Unilateral or bilateral posterior crossbite. .Patient maintains good oral hygiene and overall health.
- • Patient with no previous orthodontic treatment.
- • No systemic disease that may affect bone quality or interfere with orthodontic treatment.
- • Adolescent and adult patien
- Exclusion Criteria:
- • Craniofacial congenital disorders, including cleft lip and palate.
- • History of periodontal disease
About Samar Hassan Mahmoud Mohamed
Samar Hassan Mahmoud Mohamed is a dedicated clinical trial sponsor committed to advancing medical research through the support and oversight of innovative clinical studies. With a focus on ensuring ethical standards, patient safety, and scientific rigor, Samar plays a pivotal role in facilitating the development of new therapies and contributing to evidence-based healthcare improvements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Saleh Anwar Saleh, Professor of orthodontics
Study Director
ALAzhar university ,faculty of dentistry
Esmail Kamal Hewy, lecturer of orthodontics
Principal Investigator
ALAzhar university ,faculty of dentistry
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported